Canadian biotech company Providence Therapeutics has announced its support for the PaedNEO-VAX clinical study — a program testing personalized mRNA vaccines for children and teens with the most severe, treatment-resistant brain tumors. The project is set to launch in Australia in March 2026, and organizers say patient enrollment will run through a network of 7–8 pediatric hospitals and clinics across several states.
Videos
The genre of the LLM interview emerged the moment the first model was released to the public. Since then, “artificial intelligence” has been asked to prophesy the future, debate the philosophical nature of being, or simply engage in heart-to-hearts. This creates the illusion of conversation with a sentient being — a phenomenon that simultaneously frightens, astonishes, and inspires awe. Yet, we have never encountered an interview where the AI is addressed honestly, with its mask of humanity stripped away.
Artificial intelligence has rapidly become a working tool in companies, government administration, education, and everyday services within just a few years. As AI becomes more…